Colorectal cancer liver metastasis: genomic evolution and crosstalk with the liver microenvironment
- PMID: 37061644
- DOI: 10.1007/s10555-023-10107-0
Colorectal cancer liver metastasis: genomic evolution and crosstalk with the liver microenvironment
Abstract
Colorectal cancer (CRC) patients frequently develop liver metastases, which are the major cause of cancer-related mortality. The molecular basis and management of colorectal liver metastases (CRLMs) remain a challenging clinical issue. Recent genomic evidence has demonstrated the liver tropism of CRC and the presence of a stricter evolutionary bottleneck in the liver as a target organ compared to lymph nodes. This bottleneck challenging CRC cells in the liver is organ-specific and requires adaptation not only at the genetic level, but also at the phenotypic level to crosstalk with the hepatic microenvironment. Here, we highlight the emerging evidence on the clonal evolution of CRLM and review recent insights into the molecular mechanisms orchestrating the bidirectional interactions between metastatic CRC cells and the unique liver microenvironment.
Keywords: Colorectal cancer liver metastasis; Genomic evolution; Tumor immune microenvironment; Tumor metabolism; Tumor microenvironment.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment.J Extracell Vesicles. 2022 Jan;11(1):e12186. doi: 10.1002/jev2.12186. J Extracell Vesicles. 2022. PMID: 35041299 Free PMC article.
-
Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.Cancer Lett. 2020 Feb 1;470:84-94. doi: 10.1016/j.canlet.2019.10.016. Epub 2019 Oct 11. Cancer Lett. 2020. PMID: 31610266
-
Colorectal liver metastasis: molecular mechanism and interventional therapy.Signal Transduct Target Ther. 2022 Mar 4;7(1):70. doi: 10.1038/s41392-022-00922-2. Signal Transduct Target Ther. 2022. PMID: 35246503 Free PMC article. Review.
-
Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.Cancer Med. 2022 Jan;11(2):492-506. doi: 10.1002/cam4.4452. Epub 2021 Dec 7. Cancer Med. 2022. PMID: 34874125 Free PMC article.
-
Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches.J Exp Clin Cancer Res. 2023 Jul 22;42(1):177. doi: 10.1186/s13046-023-02729-7. J Exp Clin Cancer Res. 2023. PMID: 37480104 Free PMC article. Review.
Cited by
-
KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2.Acta Pharm Sin B. 2024 Jul;14(7):2959-2976. doi: 10.1016/j.apsb.2024.04.024. Epub 2024 Apr 24. Acta Pharm Sin B. 2024. PMID: 39027256 Free PMC article.
-
[High expression of hexokinase 2 promotes proliferation, migration and invasion of colorectal cancer cells by activating the JAK/STAT pathway and regulating tumor immune microenvironment].Nan Fang Yi Ke Da Xue Xue Bao. 2025 Mar 20;45(3):542-553. doi: 10.12122/j.issn.1673-4254.2025.03.12. Nan Fang Yi Ke Da Xue Xue Bao. 2025. PMID: 40159969 Free PMC article. Chinese.
-
Orosomucoid 2 upregulation mediates liver injury-induced colorectal cancer liver metastasis by promoting EMT and cell migration.Cancer Sci. 2025 Jan;116(1):44-55. doi: 10.1111/cas.16131. Epub 2024 Mar 12. Cancer Sci. 2025. PMID: 38475962 Free PMC article.
-
Integrin β6 expression in colorectal cancer cells promotes liver metastasis through enhanced adhesion to endothelial fibronectin.Int J Cancer. 2025 Oct 1;157(7):1481-1495. doi: 10.1002/ijc.35504. Epub 2025 Jun 9. Int J Cancer. 2025. PMID: 40488391 Free PMC article.
-
Quantitative X-ray phase-contrast digital histology of liver metastases in a mouse model.Sci Rep. 2025 May 26;15(1):18410. doi: 10.1038/s41598-025-96049-9. Sci Rep. 2025. PMID: 40419753 Free PMC article.
References
-
- Biller, L. H., & Schrag, D. (2021). Diagnosis and treatment of metastatic colorectal cancer: A review. JAMA, 325(7), 669–685. https://doi.org/10.1001/jama.2021.0106 - DOI - PubMed
-
- Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019). Colorectal cancer. Lancet, 394(10207), 1467–1480. https://doi.org/10.1016/S0140-6736(19)32319-0 - DOI - PubMed
-
- Tsilimigras, D. I., Brodt, P., Clavien, P. A., Muschel, R. J., D'Angelica, M. I., Endo, I., et al. (2021). Liver metastases. Nature Reviews Disease Primers, 7(1), 27. https://doi.org/10.1038/s41572-021-00261-6 - DOI - PubMed
-
- Milette, S., Sicklick, J. K., Lowy, A. M., & Brodt, P. (2017). Molecular pathways: Targeting the Microenvironment of liver metastases. Clinical Cancer Research, 23(21), 6390–6399. https://doi.org/10.1158/1078-0432.CCR-15-1636 - DOI - PubMed - PMC
-
- Hess, K. R., Varadhachary, G. R., Taylor, S. H., Wei, W., Raber, M. N., Lenzi, R., et al. (2006). Metastatic patterns in adenocarcinoma. Cancer, 106(7), 1624–1633. https://doi.org/10.1002/cncr.21778 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical